The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 04, 2022
Filed:
Jun. 14, 2018
Applicants:
Muhammed Majeed, Edison, NJ (US);
Kalyanam Nagabhushanam, East Windsor, NJ (US);
Inventors:
Muhammed Majeed, Edison, NJ (US);
Kalyanam Nagabhushanam, East Windsor, NJ (US);
Assignee:
SAMI LABS LIMITED, Bangalore, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/352 (2006.01); A61P 27/06 (2006.01); A61P 25/28 (2006.01); A61P 25/16 (2006.01); A61K 36/185 (2006.01); A61P 39/00 (2006.01); A61K 31/353 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 36/185 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61P 27/06 (2018.01); A61P 39/00 (2018.01); A61K 9/0053 (2013.01);
Abstract
Disclosed are the uses of compositions containing not less than 10% w/w of Oroxylin A, not less than 10% w/w of Baicalein and not less than 2% w/w of Chrysin in inhibiting the activity and expression of β secretase. The invention also discloses the reduction of amyloid content in PS-70 cells using the abovementioned composition. Further, the invention mentions the use of the composition for the therapeutic management of β secretase mediated disorders.